These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 25721756)

  • 61. A Model System for Studying the DNMT3A Hotspot Mutation (DNMT3A
    Lu R; Wang J; Ren Z; Yin J; Wang Y; Cai L; Wang GG
    Cancer Res; 2019 Jul; 79(14):3583-3594. PubMed ID: 31164355
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Research progress on DNMT3A gene expression in Acute myeloid leukemia].
    Zhou J; Wu T; Liu W
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2024 Aug; 41(8):1010-1015. PubMed ID: 39097288
    [TBL] [Abstract][Full Text] [Related]  

  • 63. DNMT3A Mutation-Induced CDK1 Overexpression Promotes Leukemogenesis by Modulating the Interaction between EZH2 and DNMT3A.
    Yang Y; Dai Y; Yang X; Wu S; Wang Y
    Biomolecules; 2021 May; 11(6):. PubMed ID: 34067359
    [No Abstract]   [Full Text] [Related]  

  • 64. Epigenetic Guardian: A Review of the DNA Methyltransferase DNMT3A in Acute Myeloid Leukaemia and Clonal Haematopoiesis.
    Chaudry SF; Chevassut TJ
    Biomed Res Int; 2017; 2017():5473197. PubMed ID: 28286768
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Cost-effective screening of DNMT3A coding sequence identifies somatic mutation in pediatric T-cell acute lymphoblastic leukemia.
    Szarzyńska-Zawadzka B; Kosmalska M; Sędek Ł; Sonsala A; Twardoch M; Kowalczyk JR; Szczepański T; Witt M; Dawidowska M
    Eur J Haematol; 2017 Dec; 99(6):514-519. PubMed ID: 28905428
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Screening for mutation R882 in the DNMT3A gene in Chinese patients with hematological disease.
    Li Y; Zhang DF; Zhang SW; Zeng Y; Yao YG
    Int J Hematol; 2012 Aug; 96(2):229-33. PubMed ID: 22744846
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Prognostic impact of DNMT3A mutations in patients with intermediate cytogenetic risk profile acute myeloid leukemia.
    Marková J; Michková P; Burčková K; Březinová J; Michalová K; Dohnalová A; Maaloufová JS; Soukup P; Vítek A; Cetkovský P; Schwarz J
    Eur J Haematol; 2012 Feb; 88(2):128-35. PubMed ID: 21967546
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Haploinsufficiency for DNA methyltransferase 3A predisposes hematopoietic cells to myeloid malignancies.
    Cole CB; Russler-Germain DA; Ketkar S; Verdoni AM; Smith AM; Bangert CV; Helton NM; Guo M; Klco JM; O'Laughlin S; Fronick C; Fulton R; Chang GS; Petti AA; Miller CA; Ley TJ
    J Clin Invest; 2017 Oct; 127(10):3657-3674. PubMed ID: 28872462
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Decreased DNA methylation in acute myeloid leukemia patients with DNMT3A mutations and prognostic implications of DNA methylation.
    Hájková H; Marková J; Haškovec C; Sárová I; Fuchs O; Kostečka A; Cetkovský P; Michalová K; Schwarz J
    Leuk Res; 2012 Sep; 36(9):1128-33. PubMed ID: 22749068
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The methyltransferase domain of DNMT1 is an essential domain in acute myeloid leukemia independent of DNMT3A mutation.
    Bhogal B; Weir BA; Crescenzo R; Marien A; Kwon MC; Philippar U; Cowley GS
    Commun Biol; 2022 Nov; 5(1):1174. PubMed ID: 36329185
    [TBL] [Abstract][Full Text] [Related]  

  • 71. DNMT3A mutations mediate the epigenetic reactivation of the leukemogenic factor MEIS1 in acute myeloid leukemia.
    Ferreira HJ; Heyn H; Vizoso M; Moutinho C; Vidal E; Gomez A; Martínez-Cardús A; Simó-Riudalbas L; Moran S; Jost E; Esteller M
    Oncogene; 2016 Jun; 35(23):3079-82. PubMed ID: 26434589
    [TBL] [Abstract][Full Text] [Related]  

  • 72. DNMT3A mutation is a poor prognosis biomarker in AML: results of a meta-analysis of 4500 AML patients.
    Shivarov V; Gueorguieva R; Stoimenov A; Tiu R
    Leuk Res; 2013 Nov; 37(11):1445-50. PubMed ID: 23962568
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Rare occurrence of DNMT3A mutations in myelodysplastic syndromes.
    Thol F; Winschel C; Lüdeking A; Yun H; Friesen I; Damm F; Wagner K; Krauter J; Heuser M; Ganser A
    Haematologica; 2011 Dec; 96(12):1870-3. PubMed ID: 21880636
    [TBL] [Abstract][Full Text] [Related]  

  • 74. DOK6 promoter methylation serves as a potential biomarker affecting prognosis in de novo acute myeloid leukemia.
    Sun GK; Tang LJ; Zhou JD; Xu ZJ; Yang L; Yuan Q; Ma JC; Liu XH; Lin J; Qian J; Yao DM
    Cancer Med; 2019 Oct; 8(14):6393-6402. PubMed ID: 31486300
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The clinical impact of mutant DNMT3A R882 variant allele frequency in acute myeloid leukaemia.
    Linch DC; Hills RK; Burnett AK; Gale RE
    Br J Haematol; 2020 May; 189(3):e81-e86. PubMed ID: 32004382
    [No Abstract]   [Full Text] [Related]  

  • 76. Incidence and prognostic influence of DNMT3A mutations in acute myeloid leukemia.
    Thol F; Damm F; Lüdeking A; Winschel C; Wagner K; Morgan M; Yun H; Göhring G; Schlegelberger B; Hoelzer D; Lübbert M; Kanz L; Fiedler W; Kirchner H; Heil G; Krauter J; Ganser A; Heuser M
    J Clin Oncol; 2011 Jul; 29(21):2889-96. PubMed ID: 21670448
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Evaluation of DNMT3A genetic polymorphisms as outcome predictors in AML patients.
    Yuan XQ; Zhang DY; Yan H; Yang YL; Zhu KW; Chen YH; Li X; Yin JY; Li XL; Zeng H; Chen XP
    Oncotarget; 2016 Sep; 7(37):60555-60574. PubMed ID: 27528035
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Gene expression profiling of the DNMT3A R882 mutation in acute leukemia.
    Huang X; Ma D; Dong W; Li P; Lu T; He N; Tian T; Liu N; DU Y; Ji C
    Oncol Lett; 2013 Jul; 6(1):268-274. PubMed ID: 23946816
    [TBL] [Abstract][Full Text] [Related]  

  • 79. DNMT3A in haematological malignancies.
    Yang L; Rau R; Goodell MA
    Nat Rev Cancer; 2015 Mar; 15(3):152-65. PubMed ID: 25693834
    [TBL] [Abstract][Full Text] [Related]  

  • 80. RNAi-Mediated Screen of Primary AML Cells Nominates MDM4 as a Therapeutic Target in NK-AML with
    Sidorova OA; Sayed S; Paszkowski-Rogacz M; Seifert M; Camgöz A; Roeder I; Bornhäuser M; Thiede C; Buchholz F
    Cells; 2022 Mar; 11(5):. PubMed ID: 35269477
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.